Exact peptide identities attached to retained registry observations carrying this condition label.
Official registry condition
Hemorrhage peptide trials
3 selected ClinicalTrials.gov records carrying the official condition label Hemorrhage. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.
3 selected records.
2 profiles.
2008–2026 in selected records.
Indication intelligence
Selected evidence landscape
Phase labels copied from the retained ClinicalTrials.gov versions.
Overall statuses at each retained observation, not necessarily current today.
Across the connected peptide profiles, PeptideScanner also carries 60 selected PubMed records and 15 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Hemorrhage unless their own cited source says so.
Collection change ledger
Recently changed records on this condition hub
These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.
ClinicalTrials.gov record NCT00369694
PeptideScanner retained ClinicalTrials.gov record NCT00369694 at 2026-11-15T21:47:40.408Z. Its registry update date was 2008-09-25, and PeptideScanner's reviewed identity mapping was terlipressin.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- September 25, 2008
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT01700478
PeptideScanner retained ClinicalTrials.gov record NCT01700478 at 2026-11-15T22:08:31.832Z. Its registry update date was 2013-02-11, and PeptideScanner's reviewed identity mapping was vasopressin.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- February 11, 2013
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT05958342
PeptideScanner retained ClinicalTrials.gov record NCT05958342 at 2026-11-15T22:08:31.832Z. Its registry update date was 2026-10-30, and PeptideScanner's reviewed identity mapping was vasopressin.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- October 30, 2026
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Vasopressin · 2026-10-30
ClinicalTrials.gov record NCT05958342
Recruiting at the retained observation.
Open attributed record →Vasopressin · 2013-02-11
ClinicalTrials.gov record NCT01700478
Completed at the retained observation.
Open attributed record →Terlipressin · 2008-09-25
ClinicalTrials.gov record NCT00369694
Completed at the retained observation.
Open attributed record →